Fusion Pharmaceuticals In...

NASDAQ: FUSN · Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM

Fusion Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-94.9M -87.61M -81.05M
Depreciation & Amortization
1.34M 909K 634K
Stock-Based Compensation
12.44M 10.84M 8.6M
Other Working Capital
-650K 2.96M -962K
Other Non-Cash Items
-222K 2.08M 11.66M
Deferred Income Tax
845K -3.16M -991K
Change in Working Capital
-1.32M 3.66M -14.6M
Operating Cash Flow
-81.8M -73.28M -75.74M
Capital Expenditures
-3.89M -2.14M -1.49M
Cash Acquisitions
38.87M -25.23M -39.27M
Purchase of Investments
-230.57M -165.16M -172.47M
Sales Maturities Of Investments
191.7M 190.38M 211.73M
Other Investing Acitivies
-38.87M 25.23M 39.27M
Investing Cash Flow
-42.76M 23.09M 37.77M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a 1.28M n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
142.01M 40.73M 347K
Financial Cash Flow
142.01M 40.73M 347K
Net Cash Flow
17.61M -9.46M -37.62M
Free Cash Flow
-85.69M -75.42M -77.23M